Last Updated : July 12, 2013
Details
FilesGeneric Name:
Eplerenone
Project Status:
Complete
Therapeutic Area:
Heart failure, NYHA class II
Manufacturer:
Pfizer Canada Inc.
Call for patient/clinician input open:
Brand Name:
Inspra
Project Line:
Reimbursement Review
Project Number:
SR0342-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
Initial
Indications:
Heart failure, NYHA class II
Recommendation Type:
Do not list at the submitted price
Final Recommendation:
Files
Last Updated : July 12, 2013